Galmed Pharmaceuticals Ltd.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through the ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company is developing MyBiotics, which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform and Tissue Dynamics to develop a novel human chronic cardiac fibrosis model. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 80.2K | $39.29K | 0.00% | Trimmed-28.5% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-03-31 | -0.51 | -0.92 | -80.39% |
| 2025-11-26 | -0.54 | -0.33 | +38.89% |
| 2025-08-28 | -0.83 | -0.63 | +24.10% |
| 2025-05-22 | -0.89 | -0.62 | +30.34% |
| 2024-04-04 | -3.84 | -2.64 | +31.25% |
| 2023-11-22 | -3.60 | -2.88 | +20.00% |
| 2023-08-09 | -4.08 | -11.40 | -179.41% |
| 2023-06-01 | -18.00 | -13.08 | +27.33% |
| 2023-03-29 | -25.20 | -18.00 | +28.57% |
| 2022-11-16 | -27.90 | -37.80 | -35.48% |
| 2022-08-04 | -42.75 | -27.00 | +36.84% |
| 2022-05-17 | -56.70 | -43.20 | +23.81% |
| 2022-05-02 | -58.80 | -54.00 | +8.16% |
| 2021-11-08 | -68.40 | -55.80 | +18.42% |
| 2021-08-05 | -75.60 | -59.40 | +21.43% |
| 2021-05-13 | -71.10 | -68.40 | +3.80% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| GLMD | +32.05% | +23.40% | +0.40% | -47.27% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +29.08% | +28.04% | +3.84% | -59.96% |